The QuickELISA Anthrax-PA kit for in vitro diagnosis of anthrax provides labs with a simple and rapid means to confirm anthrax infection in a potential bioterrorism incident or in cases of natural exposure. The kit also can be used to monitor antibodies generated in response to vaccination against anthrax with PA-based vaccines.
The QuickELISA kit includes a 96-well breakaway microplate, and all reagents and controls come in a ready-to-use format. The turnaround time for the assay is about 45 minutes, after which results are read on a standard microplate reader. The kit detects antibodies of all isotypes in human as well as nonhuman species.
(800) 227-4765; www.immunetics.com